Rockwell Med Statistics
Rockwell Med (RMTI) Stock Statistics & Valuation Metrics
Total Valuation
Rockwell Med has a market cap or net worth of CHF 24.32M. The enterprise value is CHF 10.93M.
- Market Cap
- CHF 24.32M
- Enterprise Value
- CHF 10.93M
Share Statistics
Rockwell Med has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- ―
- Owned by Insiders
- 6.97%
- Owned by Institutions
- 4.23%
Financial Efficiency
Rockwell Med’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -9.49%.
- Return on Equity (ROE)
- -0.14
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -9.49%
- Return on Capital Employed (ROCE)
- -0.10
- Revenue Per Employee
- 441.13K
- Profits Per Employee
- -33.85K
- Employee Count
- 157
- Asset Turnover
- 1.21
- Inventory Turnover
- 16.81
Valuation Ratios
The current PE Ratio of Rockwell Med is -5.26. Rockwell Med’s PEG ratio is 0.03.
- PE Ratio
- -5.26
- PS Ratio
- 0.42
- PB Ratio
- 0.82
- Price to FCF
- 19.13
- Price to Operating Cash Flow
- 9.99
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, Rockwell Med had revenue of 69.26M and earned -5.31M in profits. Earnings per share was -1.50.
- Revenue
- 69.26M
- Gross Profit
- 11.70M
- Operating Income
- -4.69M
- Pretax Income
- -5.31M
- Net Income
- -5.31M
- EBITDA
- -2.00M
- Earnings Per Share (EPS)
- -1.50
Cash Flow
In the last 12 months, operating cash flow was 2.90M and capital expenditures -1.36M, giving a free cash flow of 1.54M billion.
- Operating Cash Flow
- 2.90M
- Free Cash Flow
- 1.54M
- Free Cash Flow per Share
- 0.39
Dividends & Yields
Rockwell Med pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.00%
- Earnings Yield
- -16.81%
Important Dates
Rockwell Med upcoming earnings date is Nov 12, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Rockwell Med as a current ratio of 3.98, with Debt / Equity ratio of 33.73%
- Current Ratio
- 3.98
- Quick Ratio
- 3.63
- Debt to Market Cap
- 0.30
- Net Debt to EBITDA
- -0.88
- Interest Coverage Ratio
- -4.17
Taxes
In the past 12 months, Rockwell Med has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Rockwell Med EV to EBITDA ratio is -18.42, with an EV/FCF ratio of 22.21.
- EV to Sales
- 0.49
- EV to EBITDA
- -18.42
- EV to Free Cash Flow
- 22.21
- EV to Operating Cash Flow
- 11.81
Balance Sheet
Rockwell Med has CHF 24.80M in cash and marketable securities with CHF 13.93M in debt, giving a net cash position of CHF 10.86M billion.
- Cash & Marketable Securities
- CHF 24.80M
- Total Debt
- CHF 13.93M
- Net Cash
- CHF 10.86M
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- CHF 6.26
Margins
Gross margin is 17.71%, with operating margin of -6.52%, and net profit margin of -7.33%.
- Gross Margin
- 17.71%
- Operating Margin
- -6.52%
- Pretax Margin
- -7.33%
- Net Profit Margin
- -7.33%
- EBITDA Margin
- -2.68%
- EBIT Margin
- -5.69%
Analyst Forecast
The average price target for Rockwell Med is CHF 16.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- CHF 16.29
- Price Target Upside
- ―
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 4
- AI Score
- ―
